Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus

Journal of Diabetes and its Complications

Volumn 11, Issue 5, 1997, Pages 307-313

  Schnell, Oliver ^a,b   Muhr, Daniela ^a   Weiss, Mayo ^a   Kirsch, Carl Martin ^c   Haslbeck, Manfred ^a   Tatsch, Klaus ^a   Standl, Eberhard ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

(3 IODOBENZYL)GUANIDINE; HEMOGLOBIN A1C; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART DENERVATION; HEART SCINTISCANNING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION;

3-IODOBENZYLGUANIDINE; ADULT; DIABETES MELLITUS, TYPE 1; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIUM; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; TECHNETIUM TC 99M SESTAMIBI;

EID: 0030832134     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(97)00015-9     Document Type: Article

References (34)

1. Ewing DJ, Campbell IW, Clarke BF: The natural history of diabetic autonomic neuropathy. Q J Med 49:95-108, 1980.
2. Sampson MJ, Wilson S, Karagiannis P, Edmonds M, Watkins PJ: Progression of diabetic autonomic neuropathy over a decade in insulin-dependent diabetics. Q J Med 75:635-646, 1990.
3. Pfeifer MA, Schumer MP: Clinical trials of diabetic neuropathy: Past, present, and future. Diabetes 44:1355-1361, 1995.
4. Greene D, Lattimer SA, Sima AAF: Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316:599-606, 1987.
5. Tesfaye S, Malik R, Ward JD: Vascular factors in diabetic neuropathy Diabetologia 37:847-854, 1994.
6. Schnell O, Muhr D, Dresel S, Tatsch K, Ziegler AG, Haslbeck M, Standl E: Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients. Diabetologia 39;970-975, 1996.
7. Ewing DJ, Clarke BF: Diagnosis and management of diabetic autonomic neuropathy. BMJ 285:916-918, 1982.
8. 123I) Iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Diabetes 44:543-549, 1995.
9. Schnell O, Kirsch C-M, Stemplinger J, Haslbeck M, Standl E: Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy. Diabetologia 38:1345-1352, 1995.
10. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45:801-805, 1996.
11. 123I) Metaiodobenzylguanidine. Diabetes 41:1069-1075, 1992.
12. Claus D, Feistel H, Brunhölzl C, Platsch G, Neundörfer B, Wolf F: Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: Heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography. Clin Auton Res 4:117-123, 1994.
13. Langer A, Freeman MR, Josse RG, Armstrong PW: Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomie dysfunction and silent myocardial ischemia. JACC 25:610-618, 1995.
14. Khafagi FA, Shaprio B, Fig LM, Malette S, Sisson JC: Labetol reduces iodine-131 MIBG uptake by pheochromocytoma and normal tissues. J Nucl Med 30:481-489, 1989.
15. Ziegler D, Laux G, Dannehl K, Spüler M, Mühlen H, Mayer P, Gries FA: Assessment of cardiovascular function: Age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabetic Med 9:166-175, 1992.
16. Tobes MC, Jaques S, Wieland DM, Sisson JC: Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 26:897-907, 1985.
17. Iversen LL: Role of transmitter uptake mechanisms in synaptic neurotransmission. Br J Pharmacol 41:571-591, 1971.
18. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland DM, Glowniak JV, Sherman P, Beierwaltes WH: Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28:1625-1636, 1987.
19. Wellman HN, Zipes DP: Cardiac sympathetic imaging with radioionated metaiodobenzylguanidine (MIBG), in Zipes DP, Rowlands DJ (eds), Progress in Cardiology 3/1. Philadelphia, Lea and Febiger, 1982; pp. 161-174.
20. Degrado TR, Zalutsky MR, Vaidyanathan G: Uptake mechanisms of meta-(123I)iodobenzylguanidine in isolated rat heart. Nucl Med Biol 22:1-12, 1995.
21. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, Shinohara S: Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 27:84-89, 1986.
22. Wellman HN, Zipes DP: Cardiac sympathetic imaging with radioionated metaiodobenzylguanidine (MIBG). Prog Cardiol 3:161-174, 1990.
23. Sisson JC, Wieland DM, Sherman P: Metaiodo-benzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 28:1620-1624, 1987.
24. Mangner TJ, Tobes MC, Wieland DM, Sisson JC, Shapiro B: Metabolism of iodine-131-metaiodobenzylguanidine in patients with metastatic pheochromozytoma. J Nucl Med 27:37-44, 1986.
25. Dae MW, O'Connell W, Botvinick EH, Ahearn T, Yee E, Huberty JP, Mori H, Chin MC, Hattner RS, Herre JM, Munoz L: Scintigraphic assessment of regional cardiac adrenergic innervation. Circulation 79:634-644, 1989.
26. Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithardt G: Regional myocardial sympathetic dysinnervation in arrythmogenic right ventricular cardiomyopathy. Circulation 89:667-683, 1994.
27. Allman KC, Stevens MJ, Wieland DM, Hutchins GD, Wolfe ER, Greene DA, Schwaiger M: Noninvasive assessment of cardiac diabetic neuropathy by carbon-11 hydroxyephedrine and positron emission tomography. J Am Coll Cardiol 22:1425-1432, 1993.
28. Shore PA, Cohn VH, Highman B, et al.: Distribution of norepinephrine in the heart. Nature 181;848-849, 1958.
29. Hartikainen L Kuikka J, Mäntysaari M, Lansimies E, Pyorala K: Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol 77:5-9, 1996.
30. De Marco T, Dae M, Yuen-Green MS, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, et al.: Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: Evidence for late reinnervation. J Am Coll Cardiol 25:927-931, 1995.
31. Guertner C, Klepzig H, Maul FD, Hartmann A, Lelbach S, Hellmann A, Hoer G: Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography. Eur J Nucl Med 20:776-782, 1993.
32. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993.
33. The St. Thomas's Diabetic Study Group: Failure of improved glycemic control to reverse diabetic autonomic neuropathy. Diabetic Med 3:330-334, 1986.
34. Nusser J, Scheuer R, Abendroth D, Illner W-D, Land W, Landgraf R: Effect of pancreatic and/or renal transplantation on diabetic autonomic neuropathy. Diabetologia 34(suppl 1):S118-S120, 1991.